Business Context and Reporting Period
This Form 6-K filing by MediWound Ltd. (Israel) is dated May 5, 2014. The document serves as a notice to shareholders regarding an upcoming extraordinary general meeting scheduled for June 12, 2014, in Yavne, Israel. The record date for voting eligibility is set for May 12, 2014.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding corporate governance and does not contain financial performance data.
Material Changes and Corporate Actions
The filing outlines three specific proposals to be voted upon at the extraordinary general meeting:
- Director Elections: The election of Ms. Sarit Firon and Dr. Avraham Havron as external directors.
- Capital Cancellation: The cancellation of NIS 7,554.92 of authorized share capital. This involves 755,492 dormant Ordinary Shares previously repurchased and held as treasury shares.
- Articles Amendment: An amendment to the Company's Amended and Restated Articles of Association to reflect the capital cancellation.
Guidance, Outlook, and Risks
The Board of Directors recommends shareholder approval for all proposals. The filing details specific voting requirements under Israeli Companies Law, including a quorum of at least 25% of voting power. Proposals regarding director elections require either a majority vote from non-controlling, disinterested shareholders or that votes against the proposal from such shareholders do not exceed 2% of aggregate voting rights. A proxy statement is expected to be distributed on or about May 19, 2014.
Investor Verification Checklist
- Verify the record date of May 12, 2014, to confirm eligibility to vote.
- Confirm the meeting date and time: June 12, 2014, at 5:00 p.m. Israel time.
- Review the upcoming proxy statement (expected May 19, 2014) for detailed voting procedures and biographies of director candidates.
- Understand the specific voting thresholds required for the election of external directors under Israeli law.